Publications du GTE
Par Galina Jepiral (Villejuif), Frédéric Castinetti (Marseille), Vincent Hautefeuille (Amiens) & Thomas Walter (Lyon).
Publications 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial — Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. PMID: 38402886.
Eric Baudin, Bernard Goichot, Alfredo Berruti, Julien Hadoux, Salma Moalla, Sandrine Laboureau, Svenja Nölting, Christelle de la Fouchardière, Tina Kienitz, Timo Deutschbein, Stefania Zovato, Laurence Amar, Magalie Haissaguerre, Henri Timmers, Patricia Niccoli, Antongiulio Faggiano, Moussa Angokai, Livia Lamartina, Florina Luca, Deborah Cosentini, Stefanie Hahner, Felix Beuschlein, Marie Attard, Matthieu Texier*, Martin Fassnacht*; on behalf of the ENDOCAN-COMETE and ENSAT Networks
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network. — J Nucl Med. 2024 Jan 11:jnumed.123.266063. doi: 10.2967/jnumed.123.266063
Al Mansour L, De Mestier L, Haissaguerre M, Afchain P, Hadoux J, Lecomte T, Morland D, Cottereau AS, De Rycke O, Tlili G, Tordo J, Janier M, Deville A, Walter T.
Publications 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network — Eur J Endocrinol. 2023 Dec 6;189(6):575-583. doi: 10.1093/ejendo/lvad157. PMID: 38039101.
Perrier M, Brugel M, Gérard L, Goichot B, Lièvre A, Lepage C, Hautefeuille V, Do Cao C, Smith D, Thuillier P, Cros J, Cadiot G, Walter T, de Mestier L.
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network — J Nucl Med. 2023 Nov;64(11):1699-1705. doi: 10.2967/jnumed.123.265584
De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A, Morland D, Goichot B, Taieb D, Walter T, Cadiot G, Cros J, Hentic O, Ruszniewski P, Lebtahi R, Imperiale A, de Mestier L.
The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery-A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study — Ann Surg Oncol . 2023 Oct 16. doi: 10.1245/s10434-023-14382-7. Online ahead of print
Kalifi M, Deguelte S, Faron M, Afchain P, de Mestier L, Lecomte T, Pasquer A, Subtil F, Alghamdi K, Poncet G, Walter T.
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines / Association Française de Chirurgie Endocrinienne / REseau NAtional de prise en charge des Tumeurs ENdocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1 — Ann Endocrinol (Paris) . 2023 Sep 20:S0003-4266(23)00707-2. doi: 10.1016/j.ando.2023.09.003. Online ahead of print
Goudet P, Cadiot G, Barlier A, Baudin E, Borson-Chazot F, Brunaud L, Caiazzo R, Cardot-Bauters C, Castinetti F, Chanson P, Cuny T, Dansin E, Gaujoux S, Giraud S, Groussin L, Bras ML, Lifante JC, Mathonnet M, de Mestier L, Mirallié E, Pattou F, Romanet P, Sebag F, Tresallet C, Vezzosi D, Walter T, Tabarin A.
Surgery of primary lung carcinoid tumors at metastatic stage: a national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network — J Neuroendocrinol . 2023 Aug 7:e13331. doi: 10.1111/jne.13331. Online ahead of print
Duponchelle L, Baudin E, Subtil F, Do Cao C, Dansin E, Perrier M, Teissier MP, Haissaguerre M, Cansouline X, Hadoux J, Jepiral G, Lombard-Bohas C, Mercier O, Tronc F, Walter T.
Recurrence after Surgery for Primary Hyperparathyroidism in 517 Patients with Multiple Endocrine Neoplasia Type 1. An AFCE and GTE study (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines) — Ann Surg. 2023 Jul 3.doi: 10.1097/SLA.0000000000005980. Online ahead of print
Santucci N, Ksiazek E, Pattou F, Baud G, Mirallié E, Frey S, Trésallet C, Sébag F, Guérin C, Mathonnet M, Christou N, Donatini G, Brunaud L, Gaujoux S, Ménégaux F, Najah H, Binquet C, Goudet P, Lifante JC
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial — Lancet Oncol . 2023 Mar;24(3):297-306. doi: 10.1016/S1470-2045(23)00001-3. Epub 2023 Feb 2.
Walter T, Lievre A, Coriat R, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C.
Publications 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study — Endocr Relat Cancer. 2022 Aug 17;29(10):569-580. doi: 10.1530/ERC-22-0102. Print 2022 Oct 1
Hadoux J, Walter T, Kanaan C, Hescot S, Hautefeuille V, Perrier M, Tauveron I, Laboureau S, Do Cao C, Petorin C, Blanchet O, Faron M, Leteurtre E, Rousselet MC, Joubert Zakeyh J, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Lombard-Bohas C, Ducreux M, Scoazec JY, Baudin E; Groupe d’Etude des Tumeurs Endocrines (GTE); ENDOCAN-RENATEN network.
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study. — Br J Surg. 2022 Aug 16;109(9):872-879. doi: 10.1093/bjs/znac006
Gaujoux S, Martin GL, Mirallié E, Regenet N, Le Bras M, Pattou F, Carnaille B, Cardot-Bauters C, Groussin L, Faron M, Chanson P, Najah H, Tabarin A, Sauvanet A, Ruszniewski P, Lifante JC, Walter T, Carrère N, Caron P, Deguelte S, Delemer B, Binquet C, Jannot AS, Goudet P.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors. — Neuroendocrinology. 2022;112(6):537-546. doi: 10.1159/000518650. Epub 2021 Jul 26.PMID: 34348346
Girot P, Baudin E, Senellart H, Bouarioua N, Hentic O, Guimbaud R, Walter T, Ferru A, Roquin G, Cadiot G, Pracht M, Girot JB, Malka D, Ducreux M, Bennouna J, Matysiak-Budnik T, Hadoux J, Touchefeu Y
Publications 2021
Pituitary adenoma in patients with multiple endocrine neoplasia type 1 - a cohort study — Eur J Endocrinol . 2021 Nov 26;185(6):863-873. doi: 10.1530/EJE-21-0630 PMID: 34636744
Le Bras M, Leclerc H, Rousseau O, Goudet P, Cuny T, Castinetti F, Bauters C, Chanson P, Tabarin A, Gaujoux S, Christin-Maitre S, Ruszniewski P, Borson-Chazot F, Guilhem I, Caron P, Goichot B, Beckers A, Delemer B, Raingeard I, Vergès B, Smati S, Wargny M, Cariou B, Hadjadj S.
Efficacy of treatments for VIPoma: A GTE multicentric series — Pancreatology . 2021 Dec;21(8):1531-1539. doi: 10.1016/j.pan.2021.08.001. Epub 2021 Aug 5
Brugel M, Walter T, Goichot B, Smith D, Lepage C, Cao CD, Hautefeuille V, Rebours V, Cadiot G, de Mestier L – Groupe d’Étude des Tumeurs Endocrines (GTE).
Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study — World J Surg . 2021 Jun;45(6):1794-1802. doi: 10.1007/s00268-021-06005-7. Epub 2021 Mar 1.
Santucci N, Gaujoux S, Binquet C, Reichling C, Lifante JC, Carnaille B, Pattou F, Mirallié E, Facy O, Mathonnet M, Goudet P.
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network — Eur J Cancer . 2021 Jul;152:100-115. doi: 10.1016/j.ejca.2021.04.030. Epub 2021 Jun 3.
Hadoux J, Kanaan C, Durand A, Hescot S, Hautefeuille V, Cadiot G, Tauveron I, Laboureau S, Do Cao C, Walter T, Petorin C, Blanchet B, Jannin A, Gu C, Faron M, Leteurtre E, Rousselet MC, Zakeyh JJ, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Ducreux M, Scoazec JY, Baudin E.
Recurrence-free survival analysis in locally advanced pheochromocytoma: first appraisal — J Clin Endocrinol Metab . 2021 Aug 18;106(9):2726-2737. doi: 10.1210/clinem/dgab202
Moog S, Castinetti F, DoCao C, Amar L, Hadoux J, Lussey-Lepoutre C, Borson-Chazot F, Vezzosi D, Drui D, Laboureau S, Raffin Sanson ML, Lamartina L, Pierre P, Batisse Ligner M, Hescot S, Al Ghuzlan A, Renaudin K, Libé R, Laroche S, Deniziaut G, Gimenez-Roqueplo AP, Jannin A, Leboulleux S, Guerin C, Faron M, Baudin E.
Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: a GTE study. — J Clin Endocrinol Metab . 2021 Mar 25;106(4):e1673-e1682. doi: 10.1210/clinem/dgaa924.
de Mestier L, Savagner F, Brixi H, Do Cao C, Dominguez-Tinajero S, Roquin G, Goichot B, Hentic O, Dubreuil O, Hautefeuille V, Walter T, Cadiot G.
Publications 2020
Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors. — Dig Liver Dis.2020 Dec;52(12):1521-1524.doi: 10.1016/j.dld.2020.09.001. Epub 2020 Sep 20. No abstract available
Perrier M, Hentic O, Walter T, Do Cao CD, Cadiot G, de Mestier L – Groupe d’étude des Tumeurs Endocrines (GTE)
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours. — Neuroendocrinology. 2020;110(5):404-412. doi: 10.1159/000502825. Epub 2019 Aug 21.PMID: 31430756
Pellat A, Walter T, Augustin J, Hautefeuille V, Hentic O, Do Cao C, Lievre A, Coriat R, Hammel P, Dubreuil O, Cohen R, Couvelard A, André T, Svrcek M, Baudin E, Afchain P.
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'etude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne). — Ann Surg . 2020 Dec;272(6):1094-1101. doi: 10.1097/SLA.0000000000003162.
Vinault S, Mariet AS, Le Bras M, Mirallié E, Cardot-Bauters C, Pattou F, Ruszniewski P, Sauvanet A, Chanson P, Baudin E, Elias D, Menegaux F, Gaujoux S, Borson-Chazot F, Lifante JC, Caron P, Carrère N, Tabarin A, Laurent C, Klein M, Brunaud L, Niccoli P, Sebag F, Cadiot G, Kianmanesh R, Luu M, Binquet C, Goudet P.
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). — Dig Liver Dis . 2020 May;52(5):473-492. doi: 10.1016/j.dld.2020.02.011. Epub 2020 Mar 28.
de Mestier L, Lepage C, Baudin E, Coriat R, Courbon F, Couvelard A, Do Cao C, Frampas E, Gaujoux S, Gincul R, Goudet P, Lombard-Bohas C, Poncet G, Smith D, Ruszniewski P, Lecomte T, Bouché O, Walter T, Cadiot G – Thésaurus National de Cancérologie Digestive (TNCD).
Publications 2019
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study — Eur J Cancer. 2019 Dec;123:92-100. doi: 10.1016/j.ejca.2019.09.021. Epub 2019 Oct 31
Walter T, Lepage C, Coriat R, Barbier E, Cadiot G, Caroli-Bosc FX, Aparicio T, Bouhier-Leporrier K, Hentic-Dhome O, Gay F, Dupont-Gossart AC, Duluc M, Lepere C, Lecomte T, Smith D, Petorin C, Di-Fiore F, Ghiringhelli F, Legoux JL, Guimbaud R, Baudin E, Lombard-Bohas C, de Baère T for the FFCD 1104 investigators/investigators
Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a national study from the French Group of Endocrine Tumours (GTE). — Neuroendocrinology . 2020;110(5):404-412. doi: 10.1159/000502825. Epub 2019 Aug 21.
Pellat A, Walter T, Augustin J, Hautefeuille V, Hentic O, Do Cao C, Lièvre A, Coriat R, Hammel P, Dubreuil O, Cohen R, Couvelard A, André T, Svrcek M, Baudin E, Afchain P.
One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study — World J Surg . 2019 Nov;43(11):2856-2864. doi: 10.1007/s00268-019-05107-7.
Christou N, Mathonnet M, Gaujoux S, Cadiot G, Deguelte S, Kraimps JL, Lifante JC, Menegaux F, Mirallié E, Muscari F, Carnaille B, Pattou F, Sauvanet A, Goudet P.
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE) and the French NET patient association (Association de patients avec des tumeurs endocrines diverses, APTED) — Ann Surg. 2019 Jul;270(1):165-171. doi: 10.1097/SLA.0000000000002736
Rault-Petit B, Do Cao C, Guyétant S, Guimbaud R, Rohmer V, Julié C, Baudin E, Goichot B, Coriat R, Tabarin A, Ramos J, Goudet P, Hervieu V, Scoazec JY, Walter T
Reply to Letter: "Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE)" — Ann Surg. 2019 Aug;270(2):e44-e46. doi: 10.1097/SLA.0000000000003079
Walter T, Rault-Petit B, Scoazec PJ
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma — J Clin Endocrinol Metab. 2019 Apr 1;104(4):1109-1118. doi: 10.1210/jc.2018-02411
Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libé R, Ajzenberg C, Bernardeschi D, Cariou B, Chabolle F, Chabre O, Darrouzet V, Delemer B, Desailloud R, Goichot B, Esvant A, Offredo L, Herman P, Laboureau S, Lefebvre H, Pierre P, Raingeard I, Reznik Y, Sadoul JL, Hadoux J, Tabarin A, Tauveron I, Zenaty D, Favier J, Bertherat J, Baudin E, Amar L, Gimenez-Roqueplo AP; French Group of Endocrine Tumors (GTE) and COMETE network
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population — J Clin Endocrinol Metab. 2019 Mar 1;104(3):753-764. doi: 10.1210/jc.2018-01170
Romanet P, Mohamed A, Giraud S, Odou MF, North MO, Pertuit M, Pasmant E, Coppin L, Guien C, Calender A, Borson-Chazot F, Béroud C, Goudet P, Barlier A – Study from TENGEN network
Publication 2018
Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors. — Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):153-159.
Plante A, Baudin E, Do Cao C, Hentic O, Dubreuil O, Terrebonne E, Granger V, Smith D, Lombard-Bohas C, Walter T.
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ?2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study — Ann Surg. 2018 Jul;268(1):158-164
Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallié E, Le Bras M, Sebag F, Niccoli P, Deguelte S, Cadiot G, Poncet G, Lifante JC, Borson-Chazot F, Chaffanjon P, Chabre O, Menegaux F, Baudin E, Ruszniewski P, Du Boullay H, Goudet P.
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study — World J Surg. 2018 Jan;42(1):143-152.
Lecomte P, Binquet C, Le Bras M, Tabarin A, Cardot-Bauters C, Borson-Chazot F, Lombard-Bohas C, Baudin E, Delemer B, Klein M, Vergès B, Aparicio T, Cosson E, Beckers A, Caron P, Chabre O, Chanson P, Du Boullay H, Guilhem I, Niccoli P, Rohmer V, Guigay J, Vulpoi C, Scoazec JY, Goudet P.
Chemotherapy in Well-Differentiated Pancreatic Neuroendocrine Tumours with Ki-67 ?10%: Is there a More Effective Antitumor Regimen A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE) — Neuroendocrinology. 2018;106(1):38-46
Roquin G, Baudin E, Lombard-Bohas C, Cadiot G, Dominguez S, Guimbaud R, Niccoli P, Legoux JL, Mitry E, Rohmer V, Ruszniewski P, Walter T, Ducreux M, Couvelard A, Scoazec JY, Ramond-Roquin A, Caroli-Bosc FX, Hentic O
Publications 2017
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE) — Endocrine . 2017 Sep;57(3):504-511. doi: 10.1007/s12020-017-1355-9. Epub 2017 Jun 29
Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort. — Eur J Cancer. 2017 May 11;79:158-165
Walter T, Tougeron D, Baudin E, Le Malicot K, Lecomte T, Malka D, Hentic O, Manfredi S, Bonnet I, Guimbaud R, Coriat R, Lepère C, Desauw C, Thirot-Bidault A, Dahan L, Roquin G, Aparicio T, Legoux JL, Lombard-Bohas C, Scoazec JY, Lepage C, Cadiot G; CEPD investigators
Publications 2015
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d’etude des Tumeurs Endocrines study — Eur J Endocrinol. 2015 Dec;173(6):819-26
J Thevenon, A Bourredjem, L Faivre, C Cardot-Bauters, A Calender, M Le Bras, S Giraud, P Niccoli, M F Odou, F Borson-Chazot, A Barlier, C Lombard-Bohas, E Clauser, A Tabarin, E Pasmant, O Chabre, E Castermans, P Ruszniewski, J Bertherat, B Delemer, S Christin-Maitre, A Beckers, I Guilhem, V Rohmer, B Goichot, P Caron, E Baudin, P Chanson, L Groussin, H Du Boullay, G Weryha, P Lecomte, F Schillo, H Bihan, F Archambeaud, V Kerlan, N Bourcigaux, J M Kuhn, B Verges, M Rodier, M Renard, J L Sadoul, C Binquet and P Goudet
MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines. — J Clin Endocrinol Metab. 2015 Apr;100(4):1568-77
Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Lévy-Bohbot N, du Boullay H, Bertagna X, Ruszniewski P, Borson-Chazot F, Vergès B, Sadoul JL, Ménégaux F, Tabarin A, Kühn JM, d’Anella P, Chabre O, Christin-Maitre S, Cadiot G, Binquet C, Delemer B
Long-term results of the surgical management of insulinoma patients with MEN1: a GTE retrospective study — Eur J Endocrinol. 2015 Mar;172(3):309-19
Vezzosi D, Cardot-Bauters C, Bouscaren N, Lebras M, Bertholon-Grégoire M, Niccoli P, Levy-Bohbot N, Groussin L, Bouchard P, Tabarin A, Chanson P, Lecomte P, Guilhem I, Carrere N, Mirallié E, Pattou F, Peix JL, Goere D, Borson-Chazot F, Caron P, Bongard V, Carnaille B, Goudet P, Baudin E
Publications 2014
Breast-cancer predisposition in multiple endocrine neoplasia type 1. — N Engl J Med. 2014 Aug 7;371(6):583-4
Dreijerink KM, Goudet P, Burgess JR, Valk GD; International Breast Cancer in MEN1 Study Group
p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation? — Ann Endocrinol (Paris). 2014 Jul;75(3):133-40
Nozières C, Zhang CX, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, Cordier-Bussat M, Ruszniewski P, Christin-Maitre S, Murat A, Groussin L, Vezzosi D, Cardot-Bauters C, Hervieu V, Joly MO, Giraud S, Odou MF, Gimenez-Roqueplo AP, Goudet P, Borson-Chazot F, Calender A
Publications 2013
Malignant insulinoma: Recommendations for characterisation and treatment. — Ann Endocrinol (Paris). 2013 Dec;74(5-6):523-33
Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; Société française d’endocrinologie and the Groupe d’étude des tumeurs endocrines
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma. — J Clin Endocrinol Metab. 2013 Oct;98(10):4006-12
Hescot S, Leboulleux S, Amar L, Vezzosi D, Borget I, Bournaud-Salinas C, de la Fouchardiere C, Libé R, Do Cao C, Niccoli P, Tabarin A, Raingeard I, Chougnet C, Giraud S, Gimenez-Roqueplo AP, Young J, Borson-Chazot F, Bertherat J, Wemeau JL, Bertagna X, Plouin PF, Schlumberger M, Baudin E; French group of Endocrine and Adrenal tumors (Groupe des Tumeurs Endocrines-REseau NAtional des Tumeurs ENdocrines and COrtico-MEdullo Tumeurs Endocrines networks)
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia — Eur J Endocrinol. 2013 Apr 15;168(5):665-74
Bernard V, Lombard-Bohas C, Taquet MC, Caroli-Bosc FX, Ruszniewski P, Niccoli P, Guimbaud R, Chougnet CN, Goichot B, Rohmer V, Borson-Chazot F, Baudin E; French Group of Endocrine Tumors
The clinical spectrum of RET proto-oncogene mutations in codon 790. — Eur J Endocrinol. 2013 Jul 29;169(3):271-6
Bihan H, Murat A, Fysekidis M, Al-Salameh A, Schwartz C, Baudin E, Thieblot P, Borson-Chazot F, Guillausseau PJ, Cardot-Bauters C, Raingeard I, Requeda E, Sadoul JL, Reznik Y; Régis Cohen for the French Group of Endocrine Tumours
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? — Clin Endocrinol (Oxf). 2013 Mar;78(3):358-64
Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix JL, Cohen R, Guillausseau C, Charrie A, Chabre O, Cornu C, Borson-Chazot F, Rohmer V; Groupe des Tumeurs Endocrines
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study. — Hum Mol Genet. 2013 May 15;22(10):1940-8
Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre O, Castermans E, Beckers A, Ruszniewski P, Le Bras M, Delemer B, Bouchard P, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P.
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. — J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Epub 2013 Jan 4. Erratum in: J Clin Endocrinol Metab. 2013 Apr;98(4):1766
Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE Group
Publications 2012
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. — J Clin Endocrinol Metab. 2012 Jun;97(6):2093-104
Garby L, Caron P, Claustrat F, Chanson P, Tabarin A, Rohmer V, Arnault G, Bonnet F, Chabre O, Christin-Maitre S, du-Boullay H, Murat A, Nakib I, Sadoul JL, Sassolas G, Claustrat B, Raverot G, Borson-Chazot F; GTE Group
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients — Clin Cancer Res. 2012 May 15;18(10):2838-49
Speisky D, Duces A, Bièche I, Rebours V, Hammel P, Sauvanet A, Richard S, Bedossa P, Vidaud M, Murat A, Niccoli P, Scoazec JY, Ruszniewski P, Couvelard A; GTE Group, Groupe d’Etude des Tumeurs Endocrines
Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1 — Dig Liver Dis. 2012 Mar;44(3):228-34
Barbe C, Murat A, Dupas B, Ruszniewski P, Tabarin A, Vullierme MP, Penfornis A, Rohmer V, Baudin E, Le Rhun M, Gaye D, Marcus C, Cadiot G; for the Groupe d’étude des Tumeurs Endocrines (GTE)
Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. — Eur J Endocrinol. 2012 Feb;166(2):269-79
Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V, Young J, Delemer B, Du Boullay H, Verger MF, Kuhn JM, Sadoul JL, Ruszniewski P, Beckers A, Monsaingeon M, Baudin E, Goudet P, Tabarin A.
Publications 2011
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study — Dig Liver Dis. 2011 Oct;43(10):828-33.
Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E, Raoul JL, Renard P, Baudin E, Robaskiewicz M, Mitry E, Cadiot G; Groupe d’étude des Tumeurs Endocrines (GTE)
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. — Eur J Endocrinol. 2011 Jul;165(1):97-105
Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Cadiot G, Beckers A, Guilhem I, Chabre O, Caron P, Du Boullay H, Verges B, Cardot-Bauters C.
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma — Head Neck. 2011 Jun 17. doi: 10.1002/hed.21763
Bihan H, Baudin E, Meas T, Leboulleux S, Al Ghuzlan A, Hannoteaux V, Travagli JP, Valleur P, Guillausseau PJ, Cohen R; for the French Group of Endocrine Tumors (GTE)
Ectopic ACTH syndrome in children and adolescents — J Clin Endocrinol Metab. 2011 May;96(5):1213-22
More J, Young J, Reznik Y, Raverot G, Borson-Chazot F, Rohmer V, Baudin E, Coutant R, Tabarin A; Groupe Français des Tumeurs Endocrines (GTE)
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study. — Int J Biol Markers. 2011 Apr-Jun;26(2):94-101
Vezzosi D, Walter T, Laplanche A, Raoul JL, Dromain C, Ruszniewski P, d’Herbomez M, Guigay J, Mitry E, Cadiot G, Leboulleux S, Lombard-Bohas C, Borson-Chazot F, Ducreux M, Baudin E.
Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines — J Clin Endocrinol Metab. 2011 Mar;96(3):E509-18
Rohmer V, Vidal-Trecan G, Bourdelot A, Niccoli P, Murat A, Wemeau JL, Borson-Chazot F, Schvartz C, Tabarin A, Chabre O, Chabrier G, Caron P, Rodien P, Schlumberger M, Baudin E; Groupe Français des Tumeurs Endocrines
Publications 2010
Chromogranin A assay in clinical practice — Ann Endocrinol (Paris). 2010 Sep;71(4):274-80
D’Herbomez M, Do Cao C, Vezzosi D, Borzon-Chasot F, Baudin E; groupe des tumeurs endocrines (GTE France)
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. — C.World J Surg. 2010 Feb;34(2):249-55
Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A, Bonithon-Kopp
Publications 2009
Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines) — World J Surg. 2009 Jun;33(6):1197-207
Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay Choplin H, Chapuis Y, Kraimps JL, Sadoul JL, Tabarin A, Vergès B, Carnaille B, Niccoli-Sire P, Costa A, Calender A; GTE network (Groupe des Tumeurs Endocrines)
Publications 2008
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma? — Clin Endocrinol (Oxf). 2008 Sep;69(3):506-10
Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d’Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P; Groupe d’Etude des Tumeurs Endocrines (GTE)
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. — Am J Surg Pathol. 2008 Apr;32(4):534-43
Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A; Groupe d’études des Tumeurs Endocrines
Publications 2007
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. — Eur J Endocrinol. 2007 Dec;157(6):749-55
D’Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL; French Group GTE (Groupe des Tumeurs Endocrines)
A Multiple endocrine neoplasia type-1 observatory in a French-speaking area. A tool from the Endocrine Tumor study Group (GTE). — Ann Endocrinol (Paris). 2007 Jun;68(2-3):154-9
Goudet P, Bonithon C, Costa A, Cadiot G, Baudin E, Murat A, Delemer B, Tabarin A, Lecomte P, Calender A; Endocrine Tumor Study Group (GTE)
Publications 2006
Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor ? An analysis of 65 patients from the GTE — World J Surg. 2006 May;30(5):654-62; discussion 663-4
Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA; French Endocrine Tumor Study Group
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1 — Am J Gastroenterol. 2006 Feb;101(2):266-73
Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O, Jovenin N, Cadiot G; Groupe des Tumeurs Endocrines (GTE)
Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas — Ann Surg. 2006 Feb;243(2):265-72
Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA.
Publications 2005
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma — J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84
Barbet J, Campion L, Kraeber-Bodéré F, Chatal JF; GTE Study Group
Publications 2004
Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry — Gastroenterol Clin Biol. 2004 Nov;28(11):1075-81
Lévy-Bohbot N, Merle C, Goudet P, Delemer B, Calender A, Jolly D, Thiéfin G, Cadiot G; Groupe des Tumeurs Endocrines
Gastrinomas in multiple endocrine neoplasia type-1. A 127-case cohort study from the endocrine tumor group (ETG) — Ann Chir. 2004 Apr;129(3):149-55. French
Goudet P, Peschaud F, Mignon M, Nicoli-Sire P, Cadiot G, Ruszniewski P, Calender A, Murat A, Sarfati E, Peix JL, Kraimps JL, Henry JF, Cougard P, Proye C; Groupe des Tumeurs Endocrines
Publications 2003
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations ? — Surgery. 2003 Dec;134(6):1029-36; discussion 1036-7.doi: 10.1016/j.surg.2003.07.019
Niccoli-Sire P , Murat A, Rohmer V, Gibelin H, Chabrier G, Conte-Devolx B, Visset J, Ronceray J, Jaeck D, Henry JF, Proye C, Carnaille B, Kraimps JL, Groupe d’étude des Tumeurs Endocrines